NRG PALLAS and partners celebrate the start of the PALLAS-reactor construction
The preparations are complete and the actual construction can begin.
Today, Anita van den Ende, Secretary-General of the Ministry of Health, Welfare and Sport, gave the go-ahead for the construction of the PALLAS-reactor.
On 1 July 2025, the Minister of Health, Welfare and Sport informed the House of Representatives that NRG PALLAS could enter the construction phase of the PALLAS-reactor. The preparatory works were previously completed with the site preparations and delivery of the construction pit that lays the reactor building’s foundation.
Maurits Wolleswinkel, CEO NRG PALLAS: "Every day, thousands of patients depend on medical isotopes produced in Petten for their diagnosis or treatment. With the construction of the PALLAS-reactor to replace the High Flux Reactor, we are ensuring security of supply of medical isotopes in the future. This will make the Netherlands and Europe less dependent on other countries. Developments in the field of therapeutic isotopes are very promising. We want to contribute to better and more efficient patient care through the development and production of new isotopes."
Peter Dijk, PALLAS Programme director: "The PALLAS-reactor is a major infrastructure project and requires careful preparation. Together with the Ministry of Health, Welfare and Sport, we have gone through all the steps to become a state-owned company and to secure financing.
Together with our construction partner FCC and design partner ICHOS, we have reached the point where construction of the reactor building can begin. We are proud of what we have achieved together and what we are yet to achieve: building a reactor in the construction pit."
The PALLAS-reactor: of vital importance
NRG PALLAS specializes in the production of medical isotopes and the development of advanced nuclear technologies. The new PALLAS-reactor will replace the current High Flux Reactor and secure the supply of isotopes for the diagnosis and treatment of more than 30,000 patients per day. This number is expected to increase due to the introduction of new treatments with medical isotopes and the growth in the number of patients with cancer and cardiovascular disease worldwide.
